About pSivida
pSivida is a company based in Watertown (United States) founded in 1987. The company has 49 employees as of December 31, 2018. pSivida has completed 1 acquisition, including EyePoint Pharmaceuticals. pSivida operates in a competitive market with competitors including Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.
- Headquarter Watertown, United States
- Employees 49 as on 31 Dec, 2018
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Psivida Corp.
-
Annual Revenue
$3.1 M (USD)210as on Dec 31, 2024
-
Net Profit
-$130.87 M (USD)-85as on Dec 31, 2024
-
EBITDA
-$145.85 M (USD)-94as on Dec 31, 2024
-
Latest Funding Round
$60.5 M (USD), Post-IPO
Mar 28, 2018
-
Investors
RA Capital
& 2 more
-
Employee Count
49
as on Dec 31, 2018
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of pSivida
Unlock access to complete
Unlock access to complete
Software Development Team
25 people
Leadership Team
23 people
Scientific Team
6 people
Operations Team
6 people
Finance and Accounting
5 people
Product Management Team
4 people
Legal and Compliance
3 people
Human Resources and Administration
3 people
Unlock access to complete
Funding Insights of pSivida
Investors in pSivida
pSivida has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include RA Capital, SWK Holdings and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked | |
|
Investments and advisory services are provided by the holding company.
|
Locked | Locked | Locked | |
|
RA Capital is engaged in evidence-based investing in healthcare and life sciences.
|
Locked | Locked | Locked |
Investor details for pSivida
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by pSivida
pSivida has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include EyePoint Pharmaceuticals.
Investment portfolio details for pSivida
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for ophthalmic disorders are developed.
|
Locked | Locked | 1987 | Locked |
Complete acquisition details for pSivida
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - pSivida
Detailed financials for pSivida
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Psivida Comparisons
Peer comparison for pSivida
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of pSivida
pSivida operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rezolute, Aviceda Therapeutics, EyePoint Pharmaceuticals, Molecular Partners and CureVac, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for metabolic and orphan diseases are developed by Rezolute.
|
|
| Locked | Locked | Locked |
Biotherapeutics for glycol-immune diseases are developed across multiple therapeutic areas.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for ophthalmic disorders are developed.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for diseases are developed using DARPin technology.
|
|
| Locked | Locked | Locked |
mRNA-based therapeutics against cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Gene therapy solutions for retinal diseases are developed.
|
Detailed competitors of pSivida
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Psivida
Complete news archive for pSivida
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about pSivida
pSivida was founded in 1987 and raised its 1st funding round 25 years after it was founded.
pSivida is headquartered in Watertown, United States.
Paul Ashton is the current CEO of pSivida.
As of Dec 31, 2018, the latest employee count at pSivida is 49.
Annual revenue of pSivida is $3.1M as on Dec 31, 2024.
Founded in 1987 and based in Watertown, United States, pSivida operates in the biotechnology sector, focusing on sustained-release drug delivery technologies. Products such as Durasert and Tethadur are licensed to partners including Pfizer and Alimera Sciences for applications in ophthalmology. FDA-approved offerings like ILUVIEN for diabetic macular edema and Retisert for uveitis are utilized through intravitreal implants, with administration controlled for months or years.
pSivida's top competitors include EyePoint Pharmaceuticals, Rezolute and Molecular Partners.
pSivida has made 1 acquisition, including EyePoint Pharmaceuticals.
pSivida has 3 investors. Key investors include RA Capital, SWK Holdings, and EW Healthcare Partners.